Full Text View
Tabular View
No Study Results Posted
Related Studies
28-Day Study of Testosterone Co-Administered With Dutasteride in Hypogonadal Men
This study has been completed.
Study NCT00398580   Information provided by GlaxoSmithKline
First Received: November 8, 2006   Last Updated: May 15, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypogonadism
More general conditions related to this trial
Endocrine System Diseases
Gonadal Disorders
Interventions listed in this trial
Nanomilled testosterone
Nanomilled dutasteride
commercially available dutasteride
Additional drug interventions recognized in this trial
Dutasteride
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
More general drug interventions related to this trial
Anabolic Agents
Androgens
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Enzyme Inhibitors
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services